| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Internal Medicine, School of Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
2 Department of Clinical Physiopathology, School of Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
3 Department of Pediatrics School of Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
4 DEGENE Spin off, School of Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
(Requests for offprints should be addressed to M L Brandi; Email: m.brandi{at}dmi.unifi.it)
Several strands of evidence indicate that oestrogens exert a protective role against the development of colon cancer through indirect and direct effects on colonic epithelium. Oestrogen receptor ß (ERß), the predominant ER subtype in human colon, is significantly decreased in colonic tumours compared with normal mucosa suggesting a potential role in the regulation of colon tumour growth.
To investigate this hypothesis we engineered human colon cancer ER
Over-expression of ERß inhibited cell proliferation and increased cell adhesion in a ligand-independent manner. Its constitutive activation is possibly due to cross-talk with intracellular signalling pathways, as epidermal growth factor and IGF-I were able to induce ERß transactivation.
A possible mechanism by which ERß over-expression inhibits proliferation in HCT8 cells is by modulation of some key regulators of the cell cycle; there is a decrease in cyclin E and an increase in the cdk inhibitor p21CIP1. In fact, flow cytometry analysis provided evidence for blocking of the G1-S phase progression induced by ERß over-expression. The magnitude of this effect was affected by the level of ERß expression.
These results provide the first direct evidence that ERß plays an important role in colon cancer as a regulator of cell proliferation through the control of key cell cycle modulators and arrest in G1-S phase transition. These findings are compatible with the hypothesis that the loss of ERß expression could be one of the events involved in the development or progression of colon cancer.
-negative HCT8 cells in order to obtain ERß protein over-expression. Stably transfected cells were cloned and ERß expression and functionality were monitored by RT-PCR, Western blotting and transactivation in an assay using oestrogen-responsive reporter constructs.
This article has been cited by other articles:
|
|
 |
|
  C. C. Weige, K. F. Allred, and C. D. Allred Estradiol Alters Cell Growth in Nonmalignant Colonocytes and Reduces the Formation of Preneoplastic Lesions in the Colon Cancer Res., December 1, 2009; 69(23): 9118 - 9124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. PETERLIK, W. B. GRANT, and H. S. CROSS Calcium, Vitamin D and Cancer Anticancer Res, September 1, 2009; 29(9): 3687 - 3698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. BROZEK, S. KRIWANEK, E. BONNER, M. PETERLIK, and H. S. CROSS Mutual Associations between Malignancy, Age, Gender, and Subsite Incidence of Colorectal Cancer Anticancer Res, September 1, 2009; 29(9): 3721 - 3726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hartman, K. Edvardsson, K. Lindberg, C. Zhao, C. Williams, A. Strom, and J.-A. Gustafsson Tumor Repressive Functions of Estrogen Receptor {beta} in SW480 Colon Cancer Cells Cancer Res., August 1, 2009; 69(15): 6100 - 6106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yang, X.-O. Shu, H. Li, W.-H. Chow, H. Cai, X. Zhang, Y.-T. Gao, and W. Zheng Prospective cohort study of soy food intake and colorectal cancer risk in women Am. J. Clinical Nutrition, February 1, 2009; 89(2): 577 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Marino, P Galluzzo, S Leone, F Acconcia, and P Ascenzi Nitric oxide impairs the 17{beta}-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr. Relat. Cancer, June 1, 2006; 13(2): 559 - 569. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
